Skip to main navigation Skip to search Skip to main content

Large International Validation of ABSIS and PDAI Pemphigus Severity Scores

  • French Study Group on Autoimmune Bullous Skin Diseases
  • , Autoimmune Bullous Skin Disease Task Force of the European Academy of Dermatology and Venereology
  • University of Rouen
  • Université Lille-Nord de France
  • University of Bern
  • University of Parma
  • Columbus-Gemelli University Hospital
  • IRCCS Istituto Dermopatico dell'Immacolata - Roma
  • University of Zagreb
  • University of Tubingen
  • University of Freiburg
  • Hôpital Bichat
  • University of Paris XIII
  • Hǒpital Henri Mondor
  • Hôpital Saint-Louis
  • Université Paris Descartes
  • Centre Hospitalier Universitaire de Dijon
  • Centre Hospitalier Universitaire de Saint Etienne
  • Aix-Marseille University
  • Centre Hospitalier Universitaire de Rennes
  • Centre Hospitalier Universitaire de Clermont-Ferrand
  • Nantes University Hospital
  • Valence Hospital
  • Toulouse University School of Medicine
  • Centre Hospitalier Universitaire (CHU) de Bordeaux
  • University Hospital Angers
  • Limoges University Hospital
  • Reims University Hospital
  • Université François-Rabelais
  • Le Mans Hospital
  • Université Lyon 1
  • Centre Hospitalier Universitaire de Brest

Abstract

The Pemphigus Disease Area Index (PDAI) and Autoimmune Bullous Skin Disorder Intensity-Score (ABSIS) scores have been proposed to provide an objective measure of pemphigus activity. These scores have been evaluated only on already treated patients mainly with mild to moderate activity. The objective was to assess the interrater reliability of ABSIS and PDAI scores and their correlation with other severity markers in a large international study. Consecutive patients with newly diagnosed pemphigus were enrolled in 31 centers. Severity scores were recorded during a 24-month period by the same two blinded investigators. Serum was collected at each visit for ELISA measurement of anti-desmoglein antibodies. The intraclass correlation coefficient (ICC) and Spearman rank correlation coefficient were calculated. A total of 116 patients with pemphigus vulgaris (n = 84) or pemphigus foliaceus (n = 32) were included. At baseline, the ABSIS and PDAI ICCs were 0.90 (95% confidence interval [CI] = 0.85–0.93), and 0.91(95% CI = 0.87–0.94), respectively. The ICCs for PDAI were higher in moderate and extensive pemphigus (ICC = 0.82, 95% CI = 0.63–0.92 and ICC = 0.80, 95% CI = 0.62–0.90, respectively) than in patients with intermediate (significant) extent (ICC = 0.50, 95% CI = 0.27–0.68). Conversely, the ICCs for ABSIS were lower in patients with moderate extent (ICC = 0.44, 95% CI = 0.004–0.74) than in those with intermediate or extensive forms, (ICC = 0.69, 95% CI = 0.51–0.81 and ICC = 0.75, 95% CI = 0.51–0.88, respectively). During patients’ follow-up, the ICCs of both ABSIS and PDAI scores remained higher than 0.70. ABSIS and PDAI skin (r = 0.71 and r = 0.75) but not mucosal (r = 0.32 and r = 0.37) subscores were correlated with the evolution of anti-DSG1 and anti-DSG3 ELISA values, respectively. ABSIS and PDAI scores are robust tools to accurately assess pemphigus activity.

Original languageEnglish
JournalJournal of Investigative Dermatology
Volume139
Issue number1
Pages (from-to)31-37
Number of pages7
ISSN0022-202X
DOIs
Publication statusPublished - 01.2019

Funding

The study was supported by grants from the Seventh Framework Programme of the European Union (FP7-HEALTH-2007-2.4.4-1), natural course and pathophysiology of rare diseases, and the French Society of Dermatology .

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Fingerprint

Dive into the research topics of 'Large International Validation of ABSIS and PDAI Pemphigus Severity Scores'. Together they form a unique fingerprint.

Cite this